Akzo Nobel India Limited has been informed by Imperial Chemical Industries Limited (ICIL), a public shareholder, about the sale of 40,97,025 equity shares in the company. This sale, constituting approximately 9% of the total paid-up capital, was executed through a Block Deal on the National Stock Exchange of India Limited on 17th December 2025. The aggregate consideration received by ICIL for this transaction was ₹1296.09 crore (rounded off). Following this transaction, ICIL no longer holds any equity shares in Akzo Nobel India Limited. The buyers in this Block Deal are from the general public and do not include any promoters, promoter group, or group companies. The transaction is not considered a related party transaction and does not involve the sale of any undertaking, thus Regulation 37A of SEBI LODR Regulations is not applicable. The settlement for this sale is on a T+1 basis, with the expected completion date of the sale being 18th December 2025.